Among them, cancer inhibitory fractions CIF8 and CIF9 were able to induce the anti-inflammatory IL10 while suppressing the pro-inflammatory IFN-g in CD4+ T cells via Ca2+ channel modulation [187]. Here, IL10 is linked to cancer.